Release Date: 26/07/18 17:22 Summary: Appendix 3X - Initial Directors Interest Notice Price Sensitive: No Download Document 256.22KB Download
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial